219
Views
5
CrossRef citations to date
0
Altmetric
INCREASED PANCREATIC-DERIVED FACTOR LEVELS IN GDM

Increased pancreatic-derived factor (PANDER) levels in gestational diabetes mellitus

, , , , , & show all
Pages 866-868 | Received 01 Oct 2018, Accepted 24 Feb 2019, Published online: 15 Apr 2019

References

  • Caughey AB, Turrentine M. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131:e49–e64.
  • Correa A, Bardenheier B, Elixhauser A, et al. Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993–2009. Matern Child Health J. 2015;19:635–642.
  • Fadl HE, Ostlund IK, Magnuson AF, et al. Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabet Med. 2010;27:436–441.
  • Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–1868.
  • Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000;49:2208–2211.
  • Clausen TD, Mathiesen ER, Hansen T, et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab. 2009;94:2464–2470.
  • Catalano PM, Kirwan JP, Haugel-de Mouzon S, et al. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr. 2003;133:1674S–1683S.
  • Kautzky-Willer A, Prager R, Waldhausl W, et al. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care. 1997;20:1717–1723.
  • Damm P, Vestergaard H, Kuhl C, et al. Impaired insulin-stimulated nonoxidative glucose metabolism in glucose-tolerant women with previous gestational diabetes. Am J Obstet Gynecol. 1996;174:722–729.
  • Zhu Y, Xu G, Patel A, et al. Cloning, expression, and initial characterization of a novel cytokine-like gene family. Genomics. 2002;80:144–150.
  • Robert-Cooperman CE, Carnegie JR, Wilson CG, et al. Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic beta-cell function. Diabetes. 2010;59:2209–2218.
  • Shehata MM, Kamal MM, El-Hefnawy MH, et al. Association of serum pancreatic derived factor (PANDER) with beta-cell dysfunction in type 2 diabetes mellitus. J Diabetes Complications. 2017;31:748–752.
  • Burkhardt BR, Yang MC, Robert CE, et al. Tissue-specific and glucose-responsive expression of the pancreatic derived factor (PANDER) promoter. Biochim Biophys Acta. 2005;1730:215–225.
  • Yang J, Robert CE, Burkhardt BR, et al. Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells. Diabetes. 2005;54:3217–3228.
  • Cao X, Yang C, Lai F, et al. Elevated circulating level of a cytokine, pancreatic-derived factor, is associated with metabolic syndrome components in a Chinese population. J Diabetes Investig. 2016;7:581–586.
  • MarElia CB, Kuehl MN, Shemwell TA, et al. Circulating PANDER concentration is associated with increased HbA1c and fasting blood glucose in type 2 diabetic subjects. J Clin Transl Endocrinol. 2018;11:26–30.
  • Wang C, Guan Y, Yang J. Cytokines in the progression of pancreatic β-cell dysfunction. Int J Endocrinol. 2010;2010:515136.
  • Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev. 2008;29:351–366.
  • Robertson RP, Harmon J, Tran PO, et al. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004;53:S119–S124.
  • Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 2011;91:795–826.
  • Ashcroft FM, Rorsman P. Diabetes mellitus and the β cell: the last ten years. Cell. 2012;148:1160–1171.
  • Poulakos P, Mintziori G, Tsirou E, et al. Comments on gestational diabetes mellitus: from pathophysiology to clinical practice. Hormones (Athens). 2015;14:335–344.
  • Buchanan TA, Xiang AH, Page KA. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol. 2012;8:639–649.
  • Mirghani Dirar A, Doupis J. Gestational diabetes from A to Z. World J Diabetes. 2017;8:489–511.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.